AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $82,000 | -47.8% | 10,745 | -20.9% | 0.00% | 0.0% |
Q3 2019 | $157,000 | -50.8% | 13,582 | -21.6% | 0.00% | -66.7% |
Q2 2017 | $319,000 | +41.2% | 17,320 | +73.0% | 0.00% | +50.0% |
Q1 2017 | $226,000 | -62.5% | 10,011 | -42.1% | 0.00% | -60.0% |
Q4 2016 | $602,000 | +223.7% | 17,297 | +127.5% | 0.01% | +150.0% |
Q3 2016 | $186,000 | -19.8% | 7,602 | -21.6% | 0.00% | 0.0% |
Q2 2016 | $232,000 | -10.1% | 9,700 | -12.0% | 0.00% | 0.0% |
Q1 2016 | $258,000 | -23.2% | 11,020 | -1.1% | 0.00% | 0.0% |
Q4 2015 | $336,000 | +70.6% | 11,145 | +125.3% | 0.00% | +100.0% |
Q3 2015 | $197,000 | -71.6% | 4,947 | -50.7% | 0.00% | -80.0% |
Q2 2015 | $693,000 | +6.1% | 10,032 | -16.1% | 0.01% | +25.0% |
Q1 2015 | $653,000 | +206.6% | 11,955 | +138.8% | 0.00% | +300.0% |
Q4 2014 | $213,000 | +60.2% | 5,007 | -27.0% | 0.00% | 0.0% |
Q1 2014 | $133,000 | +3.9% | 6,855 | +14.8% | 0.00% | 0.0% |
Q3 2013 | $128,000 | – | 5,969 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |